官方APP下载:英语全能特训(微信小程序版,支持苹果手机、安卓手机)
创办于2003年
UNSV记不住?那就记中文谐音“忧安思危”吧!
  Slow and Steady Wins the Race!
UNSV英语学习频道 - Slow and steady wins the race!
公众微信服务号
英语全能特训(微信公众服务号)
UNSV英语学习频道淘宝网店
客服短信:18913948480
客服邮箱:web@unsv.com
初级VIP会员
全站英语学习资料下载。
¥98元/12个月

Study Finds Remdesivir Works Against Coronavirus 研究发现,瑞德西韦抗新冠病毒有效!

阅读次数:

免费会员开放下载 MP3节目录音 MP3节目录音  .txt格式文本
下载提示:鼠标右键点击下载链接,然后选择“目标另存为”。

VIP会员专享下载:(非VIP会员无权下载!如果想下载,但还不是VIP会员,请点此订购
下载方式:使用鼠标右键(注意是鼠标右键!)点击下面的MP3音频/MP4视频链接,然后选择“另存为…”。
MP3同步字幕 MP3同步字幕 
文章原文
同步字幕

A major study shows the experimental drug remdesivir to be effective in fighting the new coronavirus, American health officials say.

The United States National Institutes of Health led the study. It compared treatment with remdesivir to usual care in 1,063 hospitalized coronavirus patients around the world.

Anthony Fauci is the NIH's leading infectious disease expert and a member of President Donald Trump's COVID-19 task force.

Dr. Fauci said the remdesivir reduced recovery time. He said patients who received remdesivir recovered on average four days earlier than those who got usual care.

"What it has proven is that a drug can block this virus," Fauci said. "This will be the standard of care."

He also said there were fewer deaths among those who took remdesivir. The full results of the study will be published in a medical journal soon, Fauci added.

White House coronavirus response coordinator Dr. Deborah Birx listens as Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci, left, speaks at the White House, April 29, 2020, in Washington.
White House coronavirus response coordinator Dr. Deborah Birx listens as Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci, left, speaks at the White House, April 29, 2020, in Washington.

Nearly 225,000 people have died of COVID-19 and over 3 million have been infected with the coronavirus, which first appeared in China late last year.

The U.S. Food and Drug Administration said Wednesday that it has been talking with remdesivir maker, Gilead Sciences. The agency wants the company to make the drug "available to patients as quickly as possible..."

However, the drug has not been approved for any use anywhere in the world. Other possible treatments continue to be studied.

Earlier, animal studies showed remdesivir was effective against SARS and MERS, two diseases also caused by coronaviruses. It helped prevent infection and some symptoms when given early enough in the disease process.

Remdesivir is administered directly to the bloodstream through IV, a continuous fluid flow device.

"We are excited and optimistic," said Dr. Mark Denison of Vanderbilt University in Nashville, Tennessee. His laboratory tested remdesivir against other coronaviruses in 2013. It was not involved in the NIH study.

"It's active against every coronavirus that we've ever tested," Denison said. "It was very hard for the virus to develop resistance to remdesivir. That means the drug would likely be effective over longer-term use," he said.

A lab technician inspects filled vials of remdesivir at a Gilead Sciences facility in La Verne, California, March 11, 2020.
A lab technician inspects filled vials of remdesivir at a Gilead Sciences facility in La Verne, California, March 11, 2020.

A less promising result came from an incomplete study of remdesivir on severely sick patients in China. That research found the drug did not speed recovery. However, that examination was halted early, after only about half the expected patients were registered for the study. The incomplete results were reported Wednesday in the British medical journal, Lancet.

In France, a group of hospitals reported success with use of another drug, Acetemra, against COVID-19. In a study of 129 coronavirus patients, 65 were treated with the drug while the other patients received usual care. The doctors did not release details, but said they were preparing to publish results. Acetemra is used to treat rheumatoid arthritis and other diseases.

Health officials believe any vaccine for COVID-19 is at least a year away.

I'm Caty Weaver.

Hai Do adapted this story for Learning English based on Associated Press news reports. Caty Weaver was the editor.

Words in This Story

standard - n. something that is considered acceptable or desirable

journal - n. a magazine that reports on things of special interests

symptom - n. a change in the body which indicates that a disease is present

optimistic - adj. expecting good things to happen

网友的学习评论(0条):
版权所有©2003-2019 南京通享科技有限公司,保留所有权利。未经书面许可,严禁转载本站内容,违者追究法律责任。 互联网经营ICP证:苏B2-20120186
网站备案:苏公网安备 32010202011039号苏ICP备05000269号-1中国工业和信息化部网站备案查询
广播台